Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) — Results from the Multicentre Indian Pancreatic & amp; Periampullary Adenocarcinoma Project (MIPPAP) Study
ConclusionsThe MIPPAP study shows that resectable PDACs in India have survivals at par with previously published data. Adjuvant therapy was administered in 75% patients. Adjuvant radiotherapy does not seem to add to survival after R0 resection.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research
More News: Academia | Adenocarcinoma | Cancer | Cancer & Oncology | Gastroenterology | India Health | Pancreas | Pancreatic Cancer | Study